Hemostemix Inc. (TSXV:HEM)
0.0350
+0.0050 (16.67%)
Nov 20, 2026, 10:05 AM EST
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 7.4 million as of November 20, 2026. It is the 44,454th most valuable company in the world and the 1,662nd biggest in Canada. Its market cap has decreased by 53.81% in one year.
Market Cap
7.40M
Enterprise Value
10.77M
Revenue
n/a
Global Rank
Country Rank
#1,662 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 7.40M, a decrease of -84.86%. That is a compound annual growth rate of -14.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 7.40M | -57.89% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rapid Dose Therapeutics | 13.09M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.40M |
| Onco-Innovations | 9.69M |
| Marvel Biosciences | 8.49M |
| COSCIENS Biopharma | 8.19M |
| Glow Lifetech | 7.70M |
| Rakovina Therapeutics | 7.36M |